Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Person

Daniel Semenza

Tracked across 1 events · 6 articles · First seen Jun 17, 2026 · Last active Jun 18, 2026

Sentiment
20
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 20
Tech
Impact: Daniel Semenza is the lead author of the Rutgers study, highlighting his role in this significant research on GLP-1 medications and violent behavior.
Jun 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Daniel Semenza live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.